Professor Matt Trau

Matt Trau

Professor Matt Trau is at the Australian Institute of Bioengineering & Nanotechnology. Prof. Trau is developing a range of nanoscale biosensors as a strategy for disease management. These biosensors include nano-scaled biosensors for epigenetic readout in breast cancer, nano-devices for next-generation protein capture in diagnostics, and single molecule readouts via elastic nanopores. Prof. Trau is focused on developing these biosensors to monitor, personalise, and treat diseases, including infectious diseases, at early stages.

Publications

More information

On this site